Final answer:
Blue Coat's product did infringe Finjan's patent, as it performed the same function of identifying and tracking specific commands within the incoming file.
Step-by-step explanation:
Blue Coat argued that its profiles did not contain the '731 patent's required "list of computer commands." However, the court ruled that Blue Coat's product did infringe Finjan's patent. The reason is that even though Blue Coat's product did not generate an explicit list of computer commands like the '731 patent required, it still performed the same function of identifying and tracking specific commands within the incoming file, which is the essence of the '731 patent.